VV5 Stock Overview
Through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Vext Science, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.14 |
| 52 Week High | CA$0.28 |
| 52 Week Low | CA$0.13 |
| Beta | 1.73 |
| 11 Month Change | -3.33% |
| 3 Month Change | -6.45% |
| 1 Year Change | -27.50% |
| 33 Year Change | -72.90% |
| 5 Year Change | -74.34% |
| Change since IPO | -87.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| VV5 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -5.2% | 1.7% | 1.8% |
| 1Y | -27.5% | -11.1% | 13.8% |
Return vs Industry: VV5 underperformed the German Pharmaceuticals industry which returned -11.1% over the past year.
Return vs Market: VV5 underperformed the German Market which returned 13.8% over the past year.
Price Volatility
| VV5 volatility | |
|---|---|
| VV5 Average Weekly Movement | 10.1% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: VV5's share price has been volatile over the past 3 months.
Volatility Over Time: VV5's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Eric Offenberger | www.vextscience.com |
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, and Revibe brands.
Vext Science, Inc. Fundamentals Summary
| VV5 fundamental statistics | |
|---|---|
| Market cap | €37.86m |
| Earnings (TTM) | -€6.26m |
| Revenue (TTM) | €30.11m |
1.3x
P/S Ratio-6.0x
P/E RatioIs VV5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VV5 income statement (TTM) | |
|---|---|
| Revenue | US$33.33m |
| Cost of Revenue | US$25.78m |
| Gross Profit | US$7.55m |
| Other Expenses | US$14.49m |
| Earnings | -US$6.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 22.67% |
| Net Profit Margin | -20.80% |
| Debt/Equity Ratio | 40.6% |
How did VV5 perform over the long term?
See historical performance and comparison